Sickle cell retinopathy in Africa: a systematic review and meta-analysis
Documenting rates of vision-threatening complications in African sickle cell patients highlights a critical care gap that improved screening programs could address.
This systematic review and meta-analysis synthesizes the literature on sickle cell retinopathy in Africa, where the overwhelming global burden of sickle cell disease resides, documenting rates of proliferative and non-proliferative retinopathy across studies. The findings highlight a critical unmet screening and surveillance gap for a potentially blinding complication in a high-burden, under-resourced setting.
What the study was
- Study design
- Systematic review and meta-analysis
- Population
- Sickle cell disease patients in Africa
- Category
- Public Health
- Maturity
- Validated
- Journal
- Scientific Reports
Why it surfaced
Meta-analysis addressing sickle cell retinopathy in Africa — the highest SCD burden region globally, with minimal systematic screening. Highlights a significant care gap. Evidence maturity validated via systematic review design, but novelty limited as this updates existing literature.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.